Results 271 to 280 of about 65,300 (300)

“One-stitch” bioorthogonal prodrug activation based on cross-linked lipoic acid nanocapsules

Biomaterials, 2021
Pei Jing, Chunyan Liao, Yunlong Yu
exaly  

An Activatable Near‐Infrared Afterglow Theranostic Prodrug with Self‐Sustainable Magnification Effect of Immunogenic Cell Death

Angewandte Chemie - International Edition, 2022
Shaorui Jia, Hanlin Ou, Yuning Hong
exaly  

Engineering Stimuli‐Activatable Boolean Logic Prodrug Nanoparticles for Combination Cancer Immunotherapy

Advanced Materials, 2020
Bo Hou, Madiha Saeed, Dangge Wang
exaly  

Tumor Microenvironment‐Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade

Advanced Materials, 2019
Fangyuan Zhou, Bing Feng, Haijun Yu
exaly  

Dimeric prodrug-based nanomedicines for cancer therapy

Journal of Controlled Release, 2020
Shumeng Li, Jin Sun, Zhonggui He
exaly  

Abzyme prodrugs

Nature Biotechnology, 1999
openaire   +2 more sources

The double prodrug concept and its applications

Advanced Drug Delivery Reviews, 1989
Hans Bundgaard
exaly  

Prodrug approach: An overview of recent cases

European Journal of Medicinal Chemistry, 2017
Javier Recio, Julio Alvarez-Builla, Carolina Burgos   +2 more
exaly  

Phorbiplatin, a Highly Potent Pt(IV) Antitumor Prodrug That Can Be Controllably Activated by Red Light

CheM, 2019
Zhigang Wang, Shun-Cheung Cheng, Zhiqin Deng   +2 more
exaly  

pH-responsive prodrug nanoparticles based on xylan-curcumin conjugate for the efficient delivery of curcumin in cancer therapy

Carbohydrate Polymers, 2018
S Uday Kumar, Vinay Kumar, Ruchir Priyadarshi   +2 more
exaly